Rochelle T Colchico
Nurse Practitioner · Brentwood
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 11
- 1 carrier
- Offices
- 2
- Since medical school
- 8 years
- Graduated 2018
Offices
2 locations · John Muir Physician Network · 488 clinicians in this group
Looking this up.
Plans that list them
11 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Rochelle T Colchico’s office at (925) 308-8112 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
Original Medicare doctor bills
$37,227
Medicare paid this office $37,227 for 110 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 98 | $29,718 | $92 |
| Short return visit (20+ min) | 44 | $4,768 | $69 |
Who their Medicare patients are
110 Original Medicare patients in 2024. Average age 71 · Women 76% · Also on Medicaid 27% · Health risk score 1.23. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 71% · Depression 65% · Chronic kidney disease 25% · Diabetes 22% · Coronary heart disease 20% · Cancer 17% · COPD 16% · Heart failure 15% · Atrial fibrillation 13% · Dementia 10% · Stroke 10%.
The office billed $126,422, Medicare allowed $51,927 and paid $37,227; for 420 services of 8 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 110 | 420 | 71 | 1.23 | $126,422 | $37,227 |
| 2023 | 120 | 464 | 70 | 1.22 | $140,008 | $33,138 |
| 2022 | 116 | 248 | 69 | 1.26 | $75,976 | $21,104 |
| 2021 | 24 | 29 | 69 | 1.85 | $10,259 | $3,543 |
| 2020 | 12 | 12 | 55 | 1.47 | $2,466 | $431 |
| 2019 | 29 | 88 | 53 | 1.26 | $21,655 | $7,679 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Return visit (30+ min) | 112 | $28,661 | $73 |
| Short return visit (20+ min) | 25 | $1,507 | $52 |
| Telephone medical discussion with physician, 21-30 minutes | 13 | $1,341 | $56 |
| Long return visit (40+ min) | 14 | $1,269 | $91 |
2022: 2 services
| Return visit (30+ min) | 106 | $15,710 | $81 |
| Long return visit (40+ min) | 28 | $3,743 | $125 |
2021: 1 service
| Psychiatric diagnostic evaluation with medical services | 11 | $1,697 | $154 |
2019: 2 services
| Return visit (30+ min) | 24 | $4,925 | $82 |
| Long return visit (40+ min) | 13 | $2,003 | $105 |
Drugs they prescribed that Part D paid
$111,399
Pharmacies billed $111,399 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
2,099 generic and 92 brand-name prescriptions · $111,399 in drug cost · 258 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Belsomra | 26 | $14,754 | $567 |
| Quetiapine | 146 | $4,186 | $29 |
| Aripiprazole | 64 | $2,438 | $38 |
| Duloxetine | 57 | $2,065 | $36 |
| Buspirone | 126 | $1,935 | $15 |
See all 44 drugs
| Belsomra | 26 | $14,754 | $567 |
| Quetiapine | 146 | $4,186 | $29 |
| Aripiprazole | 64 | $2,438 | $38 |
| Duloxetine | 57 | $2,065 | $36 |
| Buspirone | 126 | $1,935 | $15 |
| Bupropion Xl | 67 | $1,674 | $25 |
| Fluvoxamine Maleate | 18 | $1,461 | $81 |
| Trazodone | 145 | $1,449 | $10 |
| Mirtazapine | 73 | $1,414 | $19 |
| Desvenlafaxine Succinate Er | 31 | $1,386 | $45 |
| Carbamazepine | 12 | $1,315 | $110 |
| Lamotrigine | 93 | $1,313 | $14 |
| Divalproex Sodium Er | 12 | $1,218 | $102 |
| Risperidone Odt | 11 | $1,164 | $106 |
| Vilazodone | 20 | $1,153 | $58 |
| Dextroamphetamine-Amphetamine | 45 | $1,147 | $25 |
| Olanzapine | 40 | $1,135 | $28 |
| Escitalopram | 115 | $1,133 | $10 |
| Methylphenidate | 26 | $1,106 | $43 |
| Venlafaxine Hcl Er | 79 | $1,024 | $13 |
| Sertraline | 168 | $1,023 | $6 |
| Fluoxetine | 95 | $1,000 | $11 |
| Clozapine | 13 | $937 | $72 |
| Methylphenidate Er | 14 | $893 | $64 |
| Risperidone | 28 | $855 | $31 |
| Gabapentin | 53 | $801 | $15 |
| Doxepin | 17 | $729 | $43 |
| Divalproex | 28 | $719 | $26 |
| Paroxetine | 51 | $715 | $14 |
| Dextroamphetamine-Amphet Er | 22 | $686 | $31 |
| Bupropion Hcl Sr | 34 | $565 | $17 |
| Ziprasidone | 19 | $515 | $27 |
| Bupropion | 14 | $506 | $36 |
| Citalopram Hbr | 37 | $373 | $10 |
| Haloperidol | 12 | $353 | $29 |
| Lorazepam | 63 | $325 | $5 |
| Zolpidem | 24 | $303 | $13 |
| Hydroxyzine | 35 | $292 | $8 |
| Prazosin | 13 | $220 | $17 |
| Temazepam | 12 | $198 | $17 |
| Pregabalin | 12 | $137 | $11 |
| Amitriptyline | 15 | $119 | $8 |
| Clonazepam | 28 | $64 | $2 |
| Clonidine | 20 | $42 | $2 |
Year by year
| 2024 | 2,191 | 179 | None | 4% | $111,399 |
| 2023 | 2,299 | 191 | 0% (0) | 4% | $161,352 |
| 2022 | 999 | 166 | 0% (0) | 3% | $61,112 |
| 2021 | 172 | 51 | 0% (0) | None | $10,653 |
| 2020 | 523 | 52 | 0% (0) | 7% | $80,235 |
| 2019 | 1,072 | 67 | 0% (0) | 8% | $172,557 |
| 2018 | 29 | None | 0% (0) | None | $11,982 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 44 drugs
| Vraylar | 15 | $22,495 | $1,500 |
| Aripiprazole | 55 | $13,751 | $250 |
| Belsomra | 18 | $13,223 | $735 |
| Quetiapine | 151 | $6,485 | $43 |
| Clozapine | 14 | $3,962 | $283 |
| Buspirone | 122 | $3,125 | $26 |
| Bupropion Xl | 77 | $2,876 | $37 |
| Mirtazapine | 76 | $2,502 | $33 |
| Escitalopram | 124 | $2,308 | $19 |
| Trazodone | 135 | $2,254 | $17 |
| Olanzapine | 68 | $2,248 | $33 |
| Duloxetine | 59 | $2,095 | $36 |
| Fluoxetine | 125 | $1,873 | $15 |
| Sertraline | 172 | $1,870 | $11 |
| Carbamazepine | 19 | $1,790 | $94 |
| Methylphenidate Er | 16 | $1,635 | $102 |
| Venlafaxine Hcl Er | 81 | $1,552 | $19 |
| Desvenlafaxine Succinate Er | 17 | $1,473 | $87 |
| Gabapentin | 56 | $1,422 | $25 |
| Divalproex | 39 | $1,368 | $35 |
| Dextroamphetamine-Amphetamine | 28 | $1,266 | $45 |
| Divalproex Sodium Er | 12 | $1,197 | $100 |
| Paroxetine | 66 | $1,191 | $18 |
| Prazosin | 23 | $1,188 | $52 |
| Risperidone Odt | 13 | $1,091 | $84 |
| Methylphenidate | 23 | $1,064 | $46 |
| Lamotrigine | 74 | $1,051 | $14 |
| Pregabalin | 11 | $970 | $88 |
| Risperidone | 33 | $757 | $23 |
| Bupropion | 15 | $630 | $42 |
| Ziprasidone | 11 | $571 | $52 |
| Lorazepam | 80 | $549 | $7 |
| Bupropion Hcl Sr | 29 | $496 | $17 |
| Citalopram Hbr | 47 | $441 | $9 |
| Temazepam | 13 | $383 | $29 |
| Clonazepam | 56 | $376 | $7 |
| Haloperidol | 12 | $335 | $28 |
| Zolpidem | 40 | $325 | $8 |
| Hydroxyzine | 20 | $254 | $13 |
| Amitriptyline | 18 | $169 | $9 |
| Benztropine Mesylate | 11 | $112 | $10 |
| Clonidine | 18 | $86 | $5 |
| Metformin | 13 | $82 | $6 |
| Diazepam | 17 | $54 | $3 |
2022: 23 drugs
| Aripiprazole | 28 | $8,530 | $305 |
| Duloxetine | 32 | $3,762 | $118 |
| Quetiapine | 60 | $2,428 | $40 |
| Bupropion Xl | 31 | $1,681 | $54 |
| Olanzapine | 37 | $1,495 | $40 |
| Buspirone | 43 | $1,423 | $33 |
| Desvenlafaxine Succinate Er | 15 | $1,324 | $88 |
| Prazosin | 20 | $1,154 | $58 |
| Trazodone | 67 | $824 | $12 |
| Sertraline | 57 | $785 | $14 |
| Mirtazapine | 39 | $764 | $20 |
| Escitalopram | 56 | $762 | $14 |
| Methylphenidate | 13 | $715 | $55 |
| Fluoxetine | 47 | $714 | $15 |
| Lamotrigine | 31 | $526 | $17 |
| Clonazepam | 44 | $484 | $11 |
| Gabapentin | 23 | $451 | $20 |
| Bupropion Hcl Sr | 18 | $431 | $24 |
| Venlafaxine Hcl Er | 21 | $398 | $19 |
| Paroxetine | 24 | $348 | $14 |
| Lorazepam | 56 | $155 | $3 |
| Citalopram Hbr | 16 | $150 | $9 |
| Zolpidem | 14 | $25 | $2 |
2021: 4 drugs
| Mirtazapine | 11 | $472 | $43 |
| Sertraline | 15 | $127 | $8 |
| Olanzapine | 11 | $99 | $9 |
| Escitalopram | 11 | $81 | $7 |
2020: 18 drugs
| Invega Sustenna | 16 | $40,191 | $2,512 |
| Aripiprazole | 18 | $2,978 | $165 |
| Olanzapine Odt | 39 | $2,584 | $66 |
| Olanzapine | 48 | $1,810 | $38 |
| Divalproex Sodium Er | 27 | $1,288 | $48 |
| Divalproex | 39 | $789 | $20 |
| Benztropine Mesylate | 33 | $692 | $21 |
| Haloperidol | 12 | $672 | $56 |
| Bupropion Hcl Sr | 17 | $497 | $29 |
| Ziprasidone | 13 | $477 | $37 |
| Quetiapine | 36 | $430 | $12 |
| Hydroxyzine Pamoate | 12 | $370 | $31 |
| Hydroxyzine | 14 | $343 | $24 |
| Gabapentin | 18 | $176 | $10 |
| Trazodone | 12 | $163 | $14 |
| Risperidone | 14 | $141 | $10 |
| Lamotrigine | 11 | $76 | $7 |
| Escitalopram | 11 | $74 | $7 |
2019: 27 drugs
| Invega Sustenna | 26 | $63,307 | $2,435 |
| Abilify Maintena | 23 | $46,305 | $2,013 |
| Latuda | 17 | $18,535 | $1,090 |
| Olanzapine Odt | 79 | $6,006 | $76 |
| Aripiprazole | 41 | $2,747 | $67 |
| Clozapine | 17 | $2,273 | $134 |
| Risperidone Odt | 17 | $1,907 | $112 |
| Chlorpromazine | 11 | $1,898 | $173 |
| Divalproex | 98 | $1,849 | $19 |
| Divalproex Sodium Er | 46 | $1,774 | $39 |
| Haloperidol | 30 | $1,433 | $48 |
| Olanzapine | 96 | $1,395 | $15 |
| Benztropine Mesylate | 68 | $1,178 | $17 |
| Prazosin | 21 | $998 | $48 |
| Buspirone | 15 | $933 | $62 |
| Quetiapine | 79 | $888 | $11 |
| Bupropion Hcl Sr | 22 | $767 | $35 |
| Naltrexone | 11 | $691 | $63 |
| Trazodone | 30 | $594 | $20 |
| Hydroxyzine Pamoate | 13 | $408 | $31 |
| Bupropion Xl | 16 | $387 | $24 |
| Hydroxyzine | 39 | $354 | $9 |
| Risperidone | 28 | $315 | $11 |
| Gabapentin | 24 | $258 | $11 |
| Lamotrigine | 45 | $249 | $6 |
| Fluoxetine | 18 | $141 | $8 |
| Citalopram Hbr | 22 | $76 | $3 |
Money from drug and device companies
$28 in 2022
A payment is not proof that care is biased.
| Janssen Pharmaceuticals | Invega Sustenna | $28 | 1 payment
|
See the published payment
| Janssen Pharmaceuticals | Meals · 2022-11-28 | Invega Sustenna | $28 |
Checkups this office reported
17 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 85.7 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 77%That's most of the people this applied to. | 498 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 84%That's most of the people this applied to. | 138 |
| Bone-density scans that were not neededYounger women who got a bone scan without a medical reason | 3%That's few of the people this applied to. Better on this measure. | 32 |
| Breast cancer screeningEligible women who got a mammogram | 77%That's most of the people this applied to. | 139 |
| Cervical cancer screeningEligible women who got a Pap or HPV test | 63%That's more than half. | 201 |
| Checked for fall riskOlder patients screened for fall risk | 68%That's more than half. | 150 |
| Chlamydia Screening for WomenAs Medicare defines this measure | 42% | 53 |
| Colon cancer screeningEligible adults who got a colon cancer test | 66%That's more than half. | 250 |
See the other 9 measures
| Depression screeningPatients screened for depression, with a follow-up plan if needed | 40%That's less than half. | 52 |
| Diabetes eye examPeople with diabetes who got a retinal eye exam | 30%That's less than half. | 50 |
| Diabetes poorly controlledPeople with diabetes whose blood sugar stayed very high | 30%That's less than half. Better on this measure. | 50 |
| HIV screeningEligible patients who were screened for HIV | 33%That's less than half. | 457 |
| Medications listed in the chartVisits where the current medication list was documented | 6%That's few of the people this applied to. | 2,156 |
| Patients can see their records onlinePatients who were given electronic access to their health information | 99%That's most of the people this applied to. | 450 |
| Prescriptions sent electronicallyPrescriptions sent to the pharmacy by computer instead of paper | 100%That's most of the people this applied to. | 1,535 |
| Statin prescribed when it protects the heartPeople at cardiovascular risk who were prescribed a statin | 75%That's most of the people this applied to. | 154 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 44%That's less than half. | 224 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Did a security review of patient data
- Exchanges records both ways with other health systems
- High Priority Practices Guide of the Safety Assurance Factors for EHR Resilience (SAFER) Guides
- Improved the patient portal
- Lets patients read their visit notes
- Reports cases to public health electronically
- Reports immunizations to the state registry
- Shows lab and imaging costs when ordering tests
- Uses standard treatment protocols
- Exempt from query of the prescription drug monitoring program (pdmp)
Professional record
- NPI
- 1861785404
- Licence
- CA 745083, CA 95010133
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LP0808X (363LP0808X); Federal specialty code 163WC0400X (163WC0400X)
- Mailing address
- 597 Center Ave, Suite 150, Martinez, CA, 94553
- NPI first listed
- 2011-05-16
- NPI last updated
- 2018-09-28
This is when the NPI record was last certified, not a medical board exam.